Randomized, Double‐blind, Active‐controlled, Multicenter, Phase III Clinical Trial with Two Stages to Assess the Safety and Efficacy of Letibotulinum toxin A versus Onabotulinum toxin A for Subjects with Moderate to Severe Crow’s Feet

Multicenter Phase ◽

Crow’S Feet ◽

Onabotulinum Toxin A ◽

Two Stages

Efficacy and Safety of 400 and 800 mg Etodolac vs. 1,000 mg Paracetamol in Acute Treatment of Migraine: A Randomized, Double-blind, Crossover, Multicenter, Phase III Clinical Trial

Pain Practice ◽

10.1111/j.1533-2500.2012.00572.x ◽

2012 ◽

Vol 13 (3) ◽

pp. 191-197 ◽

Cited By ~ 5

Author(s):

Vesile Öztürk ◽

Mustafa Ertaş ◽

Betül Baykan ◽

Hadiye Şirin ◽

Aynur Özge ◽

...

Keyword(s):

Clinical Trial ◽

Acute Treatment ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Efficacy and safety of eslicarbazepine acetate as adjunctive therapy for refractory focal-onset seizures in children: A double-blind, randomized, placebo-controlled, parallel-group, multicenter, phase-III clinical trial

Epilepsy & Behavior ◽

10.1016/j.yebeh.2020.106962 ◽

2020 ◽

Vol 105 ◽

pp. 106962 ◽

Cited By ~ 3

Author(s):

Fenella Kirkham ◽

Stéphane Auvin ◽

Joana Moreira ◽

Helena Gama ◽

Amílcar C. Falcão ◽

...

Keyword(s):

Clinical Trial ◽

Adjunctive Therapy ◽

Phase Iii ◽

Efficacy And Safety ◽

Eslicarbazepine Acetate ◽

Double Blind ◽

Multicenter Phase ◽

Parallel Group

RESULTS OF THE DOUBLE-BLIND, RANDOMIZED, MULTICENTER, PHASE III CLINICAL TRIAL OF THYMOGLOBULIN VERSUS ATGAM IN THE TREATMENT OF ACUTE GRAFT REJECTION EPISODES AFTER RENAL TRANSPLANTATION1,2

Transplantation Journal ◽

10.1097/00007890-199807150-00005 ◽

1998 ◽

Vol 66 (1) ◽

pp. 29-37 ◽

Cited By ~ 217

Author(s):

A. Osama Gaber ◽

M. Roy First ◽

Raymond J. Tesi ◽

Robert S. Gaston ◽

Robert Mendez ◽

...

Keyword(s):

Clinical Trial ◽

Graft Rejection ◽

Phase Iii ◽

Double Blind ◽

Acute Graft Rejection ◽

Multicenter Phase ◽

Acute Graft

Efficacy and Safety of MT10107 (Coretox) in Poststroke Upper Limb Spasticity Treatment: A Randomized, Double-Blind, Active Drug-Controlled, Multicenter, Phase III Clinical Trial

Archives of Physical Medicine and Rehabilitation ◽

10.1016/j.apmr.2020.03.025 ◽

2020 ◽

Vol 101 (9) ◽

pp. 1485-1496

Author(s):

Junekyung Lee ◽

Min Ho Chun ◽

Young Jin Ko ◽

Shi-Uk Lee ◽

Deog Young Kim ◽

...

Keyword(s):

Clinical Trial ◽

Upper Limb ◽

Active Drug ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Multicenter Phase ◽

Limb Spasticity

Efficacy and safety of zoledronic acid in patients with moderate to severe pain induced by bone metastasis associated with solid tumor or multiple myeloma: A randomized, double-blind, multicenter phase III clinical trial

Journal of Clinical Oncology ◽

10.1200/jco.2008.26.15_suppl.14679 ◽

2008 ◽

Vol 26 (15_suppl) ◽

pp. 14679-14679

Author(s):

M. Dong ◽

F. F. Yi

Keyword(s):

Clinical Trial ◽

Multiple Myeloma ◽

Zoledronic Acid ◽

Bone Metastasis ◽

Severe Pain ◽

Phase Iii ◽

Efficacy And Safety ◽

Double Blind ◽

Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial

Human Vaccines & Immunotherapeutics ◽

10.1080/21645515.2015.1017693 ◽

2015 ◽

Vol 11 (5) ◽

pp. 1094-1102 ◽

Cited By ~ 3

Author(s):

Seung Beom Han ◽

Jung-Woo Rhim ◽

Hye Jo Shin ◽

Soo Young Lee ◽

Hyun-Hee Kim ◽

...

Keyword(s):

Clinical Trial ◽

Influenza Vaccine ◽

Safety Assessment ◽

Phase Iii ◽

Double Blind ◽

Korean Children ◽

Targeted Retreatment of Incompletely Recovered Chronic Obstructive Pulmonary Disease Exacerbations with Ciprofloxacin. A Double-Blind, Randomized, Placebo-controlled, Multicenter, Phase III Clinical Trial

American Journal of Respiratory and Critical Care Medicine ◽

10.1164/rccm.201910-2058oc ◽

2020 ◽

Vol 202 (4) ◽

pp. 549-557 ◽

Cited By ~ 1

Author(s):

Andrew I. Ritchie ◽

Simon E. Brill ◽

Ben H. Vlies ◽

Lydia J. Finney ◽

James P. Allinson ◽

...

Keyword(s):

Chronic Obstructive Pulmonary Disease ◽

Clinical Trial ◽

Pulmonary Disease ◽

Phase Iii ◽

Chronic Obstructive ◽

Double Blind ◽

Obstructive Pulmonary Disease ◽

Phase III Clinical Trial Comparing Iopamidol 250 mgI/mL and Iopamidol 300mgI/mL in Cerebral Angiography: Multicenteric, Randomized and Double Blind Study

Journal of the Korean Radiological Society ◽

10.3348/jkrs.2007.57.6.501 ◽

2007 ◽

Vol 57 (6) ◽

pp. 501

Author(s):

Hyobin Seo ◽

Moon Hee Han ◽

Bae Ju Kwon ◽

So Hyang Im ◽

Cheolkyu Jung ◽

...

Keyword(s):

Clinical Trial ◽

Cerebral Angiography ◽

Blind Study ◽

Phase Iii ◽

Double Blind Study ◽

Double Blind ◽

Phase Iii Clinical Trial

Anagliptin and sitagliptin as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, active-controlled, phase III clinical trial with a 28-week extension

Diabetes Obesity and Metabolism ◽

10.1111/dom.12429 ◽

2015 ◽

Vol 17 (5) ◽

pp. 511-515 ◽

Cited By ~ 11

Author(s):

S.-M. Jin ◽

S. W. Park ◽

K.-H. Yoon ◽

K. W. Min ◽

K.-H. Song ◽

...

Keyword(s):

Type 2 Diabetes ◽

Clinical Trial ◽

Phase Iii ◽

Double Blind ◽

Phase Iii Clinical Trial

SAT0307 Lesinurad Monotherapy in Gout Patients Intolerant to Xanthine Oxidase Inhibitors (Light): A Randomized, Double-Blind, Placebo-Controlled, 6-Month Phase III Clinical Trial

Annals of the Rheumatic Diseases ◽

10.1136/annrheumdis-2015-eular.2090 ◽

2015 ◽

Vol 74 (Suppl 2) ◽

pp. 769.1-769 ◽

Cited By ~ 3

Author(s):

A.-K. Tausche ◽

R. Alten ◽

N. Dalbeth ◽

J. Kopicko ◽

N. Bhakta ◽

...

Keyword(s):

Clinical Trial ◽

Xanthine Oxidase ◽

Phase Iii ◽

Double Blind ◽

Double Blind Placebo ◽

Xanthine Oxidase Inhibitors